Research use only
BPC-157 10mg
Synthetic BPC-157 fragment studied in tissue-repair models.
$149.00
One-time. Listed price includes a $30 shipping and fulfillment floor.
Member pricing via Chiro Peptides NY
Research-use listing · No clinician visit · No intake · Charged when you pay
No eligibility quiz, no clinician review, and no prescription. That is a commerce path, not a statement that this compound is safe to use.
For laboratory research and educational discussion only. This is not medical advice, not a diagnosis, and not instructions for human or animal use. These compounds are not FDA-approved drugs and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed clinician for any health question.
BPC-157 10mg
BPC-157 is a 15-amino-acid sequence derived from a gastric protein fragment. Most of what is published is preclinical: cell culture and animal models of gut lining, tendon, and vascular signaling. Human clinical evidence is limited. This listing is research-use material, not a prescribed medicine.
Plain language
What BPC-157 10mg is
In laboratory models, BPC-157 has been examined for effects on nitric-oxide related signaling, angiogenesis-associated pathways, and cytoskeletal proteins involved in cell migration. Those findings are experimental. They are not proof of a clinical outcome in people.
Cited mechanisms
What the literature examines
Primary papers behind each theme. Most of this work is preclinical.
How this lane works
What you are and are not buying
We run a prescription lane and a research lane, and we keep them separate on purpose. This page is the research lane.
Sold as research material
This is a catalog listing for laboratory and educational use. It is not a treatment, and buying it is not a clinical decision anyone made on your behalf.
No clinician, no prescription
There is no eligibility quiz, no intake, and no provider review on this lane. Nobody has assessed whether this compound is appropriate for you.
No protocol and no dose
We do not publish dosing, routes, or schedules for research compounds, and we will not supply them on request. Read the primary literature and the supplier label.
Not FDA-approved
These are not approved drugs and have not been evaluated by the FDA for safety, effectiveness, or quality in humans.
Good to know
In laboratory models, BPC-157 has been examined for effects on nitric-oxide related signaling, angiogenesis-associated pathways, and cytoskeletal proteins involved in cell migration. Those findings are experimental. They are not proof of a clinical outcome in people.
For laboratory research and educational discussion only. This is not medical advice, not a diagnosis, and not instructions for human or animal use. These compounds are not FDA-approved drugs and are not intended to diagnose, treat, cure, or prevent any disease. Consult a licensed clinician for any health question.
No. This listing is a research-use product sold without a clinician visit, prescription, or intake. Nothing on this page is medical advice. If you have a health question, talk to a licensed clinician — not this catalog.
Payment is charged at checkout. The supplier receives the order and ships it. Tracking appears in your portal when the carrier has a scan. There is no eligibility quiz and no prescription.
References
Scientific sources
Primary papers for readers who want them. Most of this literature is preclinical — it is not a sales argument, and it is not a reason to expect a result.
- 1.Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-32.
- 2.Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Curr Neuropharmacol. 2016;14(8):857-65.
- 3.Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JS. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774-80.
- 4.Chang CH, Tsai WC, Hsu YH, Pang JS. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-77.
- 5.Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95(3):323-33.
- 6.Seiwerth S, Rucman R, Turkovic B, et al. BPC 157 and standard angiogenic growth factors. Gastrointestinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr Pharm Des. 2018;24(18):1972-89.
Plain language
Terms you might hear
- Peptide
- A short chain of amino acids. Long enough to carry a signal, short enough to synthesize.
- Preclinical
- Research done in cells or animals rather than people. It can show a mechanism exists. It cannot show a human outcome.
- In vitro
- Literally 'in glass' — an experiment run on cells in a dish, outside a living body.
- Fibroblast
- The connective-tissue cell that produces collagen and other structural proteins. A frequent subject in repair-model papers.
- Extracellular matrix
- The scaffold of collagen and related proteins that cells sit in. Remodeling it is what most 'tissue repair' papers are actually measuring.
- Angiogenesis
- The formation of new blood vessels. Measured by markers such as VEGF in these studies.
- Lyophilized
- Freeze-dried to a powder for shelf stability. Reconstituting it with a diluent is a handling step, not a dosing instruction.
BPC-157 10mg
$149.00 · research use